4//SEC Filing
Jayne David R.W. 4
Accession 0001600620-24-000118
CIK 0001600620other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:28 PM ET
Size
6.7 KB
Accession
0001600620-24-000118
Insider Transaction Report
Form 4
Jayne David R.W.
Director
Transactions
- Award
Common Shares
2024-11-21+12,135→ 56,499 total - Award
Director Stock Option (right to buy)
2024-11-21+18,641→ 18,641 totalExercise: $8.24Exp: 2034-11-21→ Common Shares (18,641 underlying)
Footnotes (2)
- [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
- [F2]The options shall vest one year from date of grant.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001838242
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 4:28 PM ET
- Size
- 6.7 KB